Devises / ABBV
ABBV: AbbVie Inc
189.71
USD
1.30
(0.69%)
Le taux de change de ABBV a changé de 0.69% aujourd'hui. Au cours de la journée, l'instrument a été échangé à un minimum de 188.32 et à un maximum de 191.09.
Suivez la dynamique AbbVie Inc. Les cotations en temps réel vous aideront à réagir rapidement aux changements du marché. En basculant entre différentes périodes, vous pouvez surveiller les tendances et la dynamique des taux de change par minutes, heures, jours, semaines et mois. Utilisez ces informations pour prévoir les changements du marché et prendre des décisions de trading éclairées.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
ABBV Nouvelles
- Investing Factbox-Major deals involving U.S. drugmakers and biotechs over the past decade
- Investing HSBC upgrades Divi’s Laboratories stock rating to Buy on growth potential
- Investing Prime Medicine stock soars amid gene editing sector momentum
- Yahoo Finance Here's What to Expect From AbbVie's Next Earnings Report
- Seeking Alpha 2 ETFs To Prepare You For A Potential Recession
- The Motley Fool 3 No-Brainer Stocks to Buy in July
- Seeking Alpha IGA: Strong Performance From Foreign Exposure And Fully-Covered Distribution
- The Motley Fool 2 Dividend Stocks to Buy for Decades of Passive Income
- Seeking Alpha NYLI Income Builder Fund Q1 2025 Commentary
- The Motley Fool Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
- Seeking Alpha AbbVie: Q2 Earnings Warning Reflects Poor R&D, But It's Not A Red Flag (NYSE:ABBV)
- TipRanks AbbVie’s (ABBV) Forecasts Lower Q2 EPS on R&D Costs - TipRanks.com
- Seeking Alpha NYLI Epoch Global Equity Yield Fund Q1 2025 Commentary
- Benzinga Novartis' Cosentyx Fails Late-Stage Giant Cell Arteritis Trial - Novartis (NYSE:NVS)
- Seeking Alpha Aldeyra Stock: Pivotal FDA Decision After Reproxalap’s Chamber Data (NASDAQ:ALDX)
- Seeking Alpha THQ: Valuation Remains Unappealing Even If Portfolio Is Beaten-Down (NYSE:THQ)
- Seeking Alpha LENZ Therapeutics: Presbyopia Eyedrops Look Promising (NASDAQ:LENZ)
- Seeking Alpha Dividend Yield Theory Says Merck Is A Buy (NYSE:MRK)
- Seeking Alpha 2025 H1 Portfolio Review: More Ways To Win
- TipRanks AbbVie Stock (ABBV) Jumps on $2.1B Capstan Therapeutics Deal - TipRanks.com
- Investing Morgan Stanley reiterates Overweight rating on AbbVie stock at $250
- Investing Palantir, Circle Internet Surge Among Monday’s Market Cap Stock Movers
- Investing AbbVie to Host Second-Quarter 2025 Earnings Conference Call
- Reuters AbbVie to buy Capstan Therapeutics for up to $2.1 billion
Range quotidien
188.32
191.09
Range Annuel
163.81
218.67
- Clôture Précédente
- 189.91
- Ouverture
- 188.41
- Bid
- 189.71
- Ask
- 190.01
- Plus Bas
- 188.32
- Plus Haut
- 191.09
- Volume
- 5.169 K
- Changement quotidien
- 0.69%
- Changement Mensuel
- 2.45%
- Changement à 6 Mois
- 3.56%
- Changement Annuel
- 1.03%
09 juillet, mercredi
14:00
USD
- Act
- -0.3%
- Fcst
- -0.3%
- Prev
- -0.3%
14:00
USD
- Act
- -0.3%
- Fcst
- 0.1%
- Prev
- 0.0%
14:30
USD
- Act
- 7.070 M
- Fcst
- -0.418 M
- Prev
- 3.845 M
14:30
USD
- Act
- 0.464 M
- Fcst
- -0.095 M
- Prev
- -1.493 M
14:30
USD
- Act
- -1.358 M
- Fcst
- 1.217 M
- Prev
- 2.940 M
14:30
USD
- Act
- 0.059 M
- Fcst
- 0.074 M
- Prev
- 0.245 M
14:30
USD
- Act
- -0.825 M
- Fcst
- -0.179 M
- Prev
- -1.710 M
14:30
USD
- Act
- 0.278 M
- Fcst
- -0.433 M
- Prev
- -0.491 M
14:30
USD
- Act
- 0.603 M
- Fcst
- 0.018 M
- Prev
- -0.202 M
14:30
USD
- Act
- -2.658 M
- Fcst
- 2.278 M
- Prev
- 4.188 M
14:30
USD
- Act
- -0.099 M
- Fcst
- Prev
- 0.118 M
14:30
USD
- Act
- -0.2%
- Fcst
- Prev
- 0.2%
17:00
USD
- Act
- 4.362%
- Fcst
- Prev
- 4.421%
18:00
USD
- Act
- Fcst
- Prev